These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 32169100)

  • 1. Diffuse optical spectroscopic imaging reveals distinct early breast tumor hemodynamic responses to metronomic and maximum tolerated dose regimens.
    Tank A; Peterson HM; Pera V; Tabassum S; Leproux A; O'Sullivan T; Jones E; Cabral H; Ko N; Mehta RS; Tromberg BJ; Roblyer D
    Breast Cancer Res; 2020 Mar; 22(1):29. PubMed ID: 32169100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffuse optical spectroscopic imaging correlates with final pathological response in breast cancer neoadjuvant chemotherapy.
    Cerussi AE; Tanamai VW; Hsiang D; Butler J; Mehta RS; Tromberg BJ
    Philos Trans A Math Phys Eng Sci; 2011 Nov; 369(1955):4512-30. PubMed ID: 22006904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optical imaging correlates with magnetic resonance imaging breast density and reveals composition changes during neoadjuvant chemotherapy.
    O'Sullivan TD; Leproux A; Chen JH; Bahri S; Matlock A; Roblyer D; McLaren CE; Chen WP; Cerussi AE; Su MY; Tromberg BJ
    Breast Cancer Res; 2013 Feb; 15(1):R14. PubMed ID: 23433249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Near-Infrared Diffuse Optical Imaging for Early Prediction of Breast Cancer Response to Neoadjuvant Chemotherapy: A Comparative Study Using 18F-FDG PET/CT.
    Ueda S; Yoshizawa N; Shigekawa T; Takeuchi H; Ogura H; Osaki A; Saeki T; Ueda Y; Yamane T; Kuji I; Sakahara H
    J Nucl Med; 2016 Aug; 57(8):1189-95. PubMed ID: 26940765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue oxygen saturation predicts response to breast cancer neoadjuvant chemotherapy within 10 days of treatment.
    Cochran JM; Busch DR; Leproux A; Zhang Z; O'Sullivan TD; Cerussi AE; Carpenter PM; Mehta RS; Roblyer D; Yang W; Paulsen KD; Pogue B; Jiang S; Kaufman PA; Chung SH; Schnall M; Snyder BS; Hylton N; Carp SA; Isakoff SJ; Mankoff D; Tromberg BJ; Yodh AG
    J Biomed Opt; 2018 Oct; 24(2):1-11. PubMed ID: 30338678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent optical imaging during breast cancer neoadjuvant chemotherapy reveals dynamic tumor physiology in an individual patient.
    Cerussi AE; Tanamai VW; Mehta RS; Hsiang D; Butler J; Tromberg BJ
    Acad Radiol; 2010 Aug; 17(8):1031-9. PubMed ID: 20542448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optical imaging of breast cancer oxyhemoglobin flare correlates with neoadjuvant chemotherapy response one day after starting treatment.
    Roblyer D; Ueda S; Cerussi A; Tanamai W; Durkin A; Mehta R; Hsiang D; Butler JA; McLaren C; Chen WP; Tromberg B
    Proc Natl Acad Sci U S A; 2011 Aug; 108(35):14626-31. PubMed ID: 21852577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting Responses to Neoadjuvant Chemotherapy in Breast Cancer: ACRIN 6691 Trial of Diffuse Optical Spectroscopic Imaging.
    Tromberg BJ; Zhang Z; Leproux A; O'Sullivan TD; Cerussi AE; Carpenter PM; Mehta RS; Roblyer D; Yang W; Paulsen KD; Pogue BW; Jiang S; Kaufman PA; Yodh AG; Chung SH; Schnall M; Snyder BS; Hylton N; Boas DA; Carp SA; Isakoff SJ; Mankoff D;
    Cancer Res; 2016 Oct; 76(20):5933-5944. PubMed ID: 27527559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiparametric monitoring of chemotherapy treatment response in locally advanced breast cancer using quantitative ultrasound and diffuse optical spectroscopy.
    Tran WT; Childs C; Chin L; Slodkowska E; Sannachi L; Tadayyon H; Watkins E; Wong SL; Curpen B; El Kaffas A; Al-Mahrouki A; Sadeghi-Naini A; Czarnota GJ
    Oncotarget; 2016 Apr; 7(15):19762-80. PubMed ID: 26942698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance assessment of diffuse optical spectroscopic imaging instruments in a 2-year multicenter breast cancer trial.
    Leproux A; O'Sullivan TD; Cerussi A; Durkin A; Hill B; Hylton N; Yodh AG; Carp SA; Boas D; Jiang S; Paulsen KD; Pogue B; Roblyer D; Yang W; Tromberg BJ
    J Biomed Opt; 2017 Dec; 22(12):121604. PubMed ID: 29389104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sample size and power determination when limited preliminary information is available.
    McLaren CE; Chen WP; O'Sullivan TD; Gillen DL; Su MY; Chen JH; Tromberg BJ
    BMC Med Res Methodol; 2017 Apr; 17(1):75. PubMed ID: 28446127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing tumor contrast in radiographically dense breast tissue using Diffuse Optical Spectroscopic Imaging (DOSI).
    Leproux A; Durkin A; Compton M; Cerussi AE; Gratton E; Tromberg BJ
    Breast Cancer Res; 2013; 15(5):R89. PubMed ID: 24066941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo, noninvasive functional measurements of bone sarcoma using diffuse optical spectroscopic imaging.
    Peterson HM; Hoang BH; Geller D; Yang R; Gorlick R; Berger J; Tingling J; Roth M; Gill J; Roblyer D
    J Biomed Opt; 2017 Dec; 22(12):1-9. PubMed ID: 29264893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in the tumor oxygenation but not in the tumor volume and tumor vascularization reflect early response of breast cancer to neoadjuvant chemotherapy.
    Pavlov MV; Bavrina AP; Plekhanov VI; Golubyatnikov GY; Orlova AG; Subochev PV; Davydova DA; Turchin IV; Maslennikova AV
    Breast Cancer Res; 2023 Jan; 25(1):12. PubMed ID: 36717842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal examination of perfusion and angiogenesis markers in primary colorectal tumors shows distinct signatures for metronomic and maximum-tolerated dose strategies.
    Mundo AI; Muhammad A; Balza K; Nelson CE; Muldoon TJ
    Neoplasia; 2022 Oct; 32():100825. PubMed ID: 35901621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-modal diffuse optical spectroscopy for high-speed monitoring and wide-area mapping of tissue optical properties and hemodynamics.
    Lam J; Hill B; Quang T; Amelard R; Kim S; Yazdi H; Warren R; Cutler K; Tromberg B
    J Biomed Opt; 2021 Aug; 26(8):. PubMed ID: 34390234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal optical monitoring of blood flow in breast tumors during neoadjuvant chemotherapy.
    Cochran JM; Chung SH; Leproux A; Baker WB; Busch DR; DeMichele AM; Tchou J; Tromberg BJ; Yodh AG
    Phys Med Biol; 2017 Jun; 62(12):4637-4653. PubMed ID: 28402286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optical Mammography in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy: Individual Clinical Response Index.
    Anderson PG; Kalli S; Sassaroli A; Krishnamurthy N; Makim SS; Graham RA; Fantini S
    Acad Radiol; 2017 Oct; 24(10):1240-1255. PubMed ID: 28532642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of neoadjuvant chemotherapy response using diffuse optical spectroscopy in breast cancer.
    Yu YH; Zhu X; Mo QG; Cui Y
    Clin Transl Oncol; 2018 Apr; 20(4):524-533. PubMed ID: 28921461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional hemodynamic imaging markers for the prediction of pathological outcomes in breast cancer patients treated with neoadjuvant chemotherapy.
    Deng B; Muldoon A; Cormier J; Mercaldo ND; Niehoff E; Moffett N; Saksena MA; Isakoff SJ; Carp SA
    J Biomed Opt; 2024 Jun; 29(6):066001. PubMed ID: 38737790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.